Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tolerability of a Low-immunogenic Oat Cultivar (Saul) in Adults With Celiac Disease in Remission: a Prospective Interventional Study

NCT07515105 is registered in ClinicalTrials.gov with Faculty Hospital Kralovske Vinohrady as lead sponsor.

NCT NCT07515105
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07515105 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tolerability of a Low-immunogenic Oat Cultivar (Saul) in Adults With Celiac Disease in Remission: a Prospective Interventional Study
Lead sponsor
Faculty Hospital Kralovske Vinohrady
Phase
Not applicable
Overall status
Completed
Start date
January 7, 2022
Completion date
November 20, 2022
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

celiac disease